71 participants
A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-11-24
- Start Date:
- 2016-12-30
- Completion:
- 2018-01-31
Conditions
- Graft-versus-host Disease (GVHD)
Interventions
- DRUG